HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stage II endometrial carcinoma. Results and complications of a combined radiotherapeutic-surgical approach.

Abstract
Since one third of the patients with Stage II endometrial carcinoma have occult extrauterine pelvic metastases at diagnosis, adequate treatment must include the pelvic lymph nodes and parametria. Eighty-three patients with Stage II endometrial carcinoma were treated between January 1964 and December 1983. Sixty-nine patients (83%) received combined whole-pelvic irradiation and surgery, five (6%) had surgery alone and nine (11%) had radiotherapy alone. Five-year actuarial survival rates were 67%, 60%, and 38%, respectively. No pelvic recurrence occurred in the 69 patients who received the combined therapy, and there was no vaginal recurrence in the 80 patients treated with intracavity radium. There was a significantly lower incidence of pelvic lymph node metastases (P = 0.03) in patients treated with preoperative irradiation. The median time to recurrence was 17 months, with 67% of the recurrences diagnosed before 2 years, and 88% within 5 years. Ten patients (12%) incurred severe complications and three died as a result. Whole-pelvic irradiation, intracavity radium, and hysterectomy are effective treatment for occult pelvic and vaginal disease.
AuthorsD M Larson, L J Copeland, H S Gallager, J P Kong, J T Wharton, C A Stringer
JournalCancer (Cancer) Vol. 61 Issue 8 Pg. 1528-34 (Apr 15 1988) ISSN: 0008-543X [Print] United States
PMID3349418 (Publication Type: Journal Article)
Topics
  • Brachytherapy
  • Carcinoma (radiotherapy, surgery, therapy)
  • Evaluation Studies as Topic
  • Female
  • Humans
  • Hysterectomy (methods)
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local
  • Radioisotope Teletherapy
  • Uterine Neoplasms (radiotherapy, surgery, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: